Skip to main content

Pulmonary Embolism Anticoagulation >= 3 Months

CBE ID
0593
1.4 Project
National Voluntary Consensus Standards For Clinically Enriched Administrative Data
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Full Year 2009
Is Under Review
No
1.3 Measure Description

This measure identifies patients with pulmonary embolism (PE) on anticoagulation for at least 3 months after the diagnosis.

    • 1.14 Numerator

      Patients in the denominator who had at least 3 months of anticoagulation after acute pulmonary embolism

    • 1.15 Denominator

      Patients diagnosed with a PE during the first 9 months of the measurement year, who do not have contraindications to warfarin therapy (contraindications include: evidence of eye surgery, GI bleed, aortic dissection, cerebral aneurysm, pericarditis, bacterial endocarditis, pregnancy, bleeding diatheses, or head trauma during or 1 year prior to the measurement year)

    • Exclusions

      Does not have contraindications to warfarin, which includes evidence of eye surgery, GI bleed, aortic dissection, cerebral aneurysm, pericarditis, bacterial endocarditis, pregnancy, bleeding diatheses, or head trauma anytime during the two years prior to the end of the measurement year through 90 days following onset of PE

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date